Works matching IS 00099236 AND DT 2017 AND VI 101 AND IP 2
Results: 25
Understanding the Link Between Cannabinoids and Psychosis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 197, doi. 10.1002/cpt.421
- By:
- Publication type:
- Article
The Utility of Cannabidiol in the Treatment of Refractory Epilepsy.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 182, doi. 10.1002/cpt.441
- By:
- Publication type:
- Article
Reinforcer Pathology: The Behavioral Economics of Abuse Liability Testing.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 185, doi. 10.1002/cpt.443
- By:
- Publication type:
- Article
Improved Insulin Sensitivity With Angiotensin Receptor Neprilysin Inhibition in Individuals With Obesity and Hypertension.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 254, doi. 10.1002/cpt.455
- By:
- Publication type:
- Article
Focusing the Neuroscience and Societal Implications of Cognitive Enhancers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 170, doi. 10.1002/cpt.457
- By:
- Publication type:
- Article
Identifying clinically relevant sources of variability: The clopidogrel challenge.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 264, doi. 10.1002/cpt.459
- By:
- Publication type:
- Article
An International Asset Map of Clinicians, Educators, and Researchers Pursuing Better Medicine Use in Children: Initial Findings.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 274, doi. 10.1002/cpt.460
- By:
- Publication type:
- Article
Deconstructing Designer Drugs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 167, doi. 10.1002/cpt.462
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 143, doi. 10.1002/cpt.468
- Publication type:
- Article
Essential competencies in prescribing: A first european cross-sectional study among 895 final-year medical students.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 281, doi. 10.1002/cpt.521
- By:
- Publication type:
- Article
Evidence of NI-0101 pharmacological activity, an anti-TLR4 antibody, in a randomized phase I dose escalation study in healthy volunteers receiving LPS.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 200, doi. 10.1002/cpt.522
- By:
- Publication type:
- Article
The Mind Bending Quest for Cognitive Enhancers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 179, doi. 10.1002/cpt.524
- By:
- Publication type:
- Article
Repurposing Drugs for Cognition in Schizophrenia.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 191, doi. 10.1002/cpt.529
- By:
- Publication type:
- Article
Exercise Mimetics: Running Without a Road Map.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 188, doi. 10.1002/cpt.533
- By:
- Publication type:
- Article
Approaches, Challenges, and Advances in Metabolism of New Synthetic Cannabinoids and Identification of Optimal Urinary Marker Metabolites.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 239, doi. 10.1002/cpt.534
- By:
- Publication type:
- Article
Novel psychoactive substances: What educators need to know.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 173, doi. 10.1002/cpt.538
- By:
- Publication type:
- Article
Psychedelics as Medicines: An Emerging New Paradigm.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 209, doi. 10.1002/cpt.557
- By:
- Publication type:
- Article
Disruptive Potential of the Internet to Transform Illicit Drug Markets and Impact on Future Patterns of Drug Consumption.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 176, doi. 10.1002/cpt.561
- By:
- Publication type:
- Article
Focus on cannabinoids and synthetic cannabinoids.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 220, doi. 10.1002/cpt.563
- By:
- Publication type:
- Article
Potential Psychiatric Uses for MDMA.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 194, doi. 10.1002/cpt.565
- By:
- Publication type:
- Article
Medical cannabis: Another piece in the mosaic of autoimmunity?
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 230, doi. 10.1002/cpt.568
- By:
- Publication type:
- Article
Designer Drugs 2.0.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 152, doi. 10.1002/cpt.575
- By:
- Publication type:
- Article
In This Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 151, doi. 10.1002/cpt.578
- Publication type:
- Article
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 158, doi. 10.1002/cpt.579
- Publication type:
- Article
ASCPT NEWS.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 160, doi. 10.1002/cpt.580
- Publication type:
- Article